Latest Articles
Medicus Pharma CMO to lead Antev's Teverelix clinical programme - Proactive financial news
Medicus Pharma CMO to lead Antev's Teverelix clinical programme Proactive financial news
Published: Aug. 3, 2026, 2:02 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - Yahoo! Finance Canada
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix Yahoo! Finance Canada
Published: July 31, 2026, 1:24 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - ca.finance.yahoo.com
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix ca.finance.yahoo.com
Published: July 31, 2026, 1:24 p.m.
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix - Quiver Quantitative
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix Quiver Quantitative
Published: July 31, 2026, 11:40 a.m.
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix - quiverquant.com
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix quiverquant.com
Published: July 31, 2026, 11:40 a.m.
About 84 Women, Four Groups: Teverelix Endometriosis Trial - Stock Titan
About 84 Women, Four Groups: Teverelix Endometriosis Trial Stock Titan
Published: July 31, 2026, 11:30 a.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - Proactive financial news
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix Proactive financial news
Published: July 31, 2026, 9:24 a.m.
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 - The Manila Times
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 The Manila Times
Published: June 22, 2026, 11:48 a.m.
Medicus brings SkinJect and Teverelix data to Bio 2026 - Stock Titan
Medicus brings SkinJect and Teverelix data to Bio 2026 Stock Titan
Published: June 22, 2026, 11:30 a.m.
Medicus advances Teverelix and SkinJect programs with key regulatory filings - Proactive financial news
Medicus advances Teverelix and SkinJect programs with key regulatory filings Proactive financial news
Published: June 15, 2026, 7:30 p.m.
Link copied to clipboard!